SLNFP-V: A precise enabler of a new generation of functional oligosaccharides CAS: 89458-13-9

Sialyl-L-lactose-N-fucopentose V (SLNFP-V) is a star component of natural human milk oligosaccharides (HMOs) with precise structure and excellent functions, and is known as "a typical representative of advanced functional oligosaccharides". It is not only a key bioactive substance endowed by nature in breast milk, but also a core raw material and tool molecule with great development value in the fields of modern nutrition, pharmaceutical science and biomedical research. With breakthroughs in synthetic biology and glycochemistry technology, the large-scale acquisition of high-purity SLNFP-V is bringing revolutionary innovation opportunities to infant formula, targeted drug delivery, immune regulation and anti-infective therapy.

Chemical name: Sialyl-L-lactose-N-fucopentose V

Common name: SLNFP-V

Chemical formula: C₄₃H₇₂N₂O₃₃

Molecular weight: 1145.03 g/mol

CAS number: 89458-13-9

Structural features: Precision architecture determines excellent functions

SLNFP-V is an acidic pentasaccharide with a complex structure. Its unique features are:

Precise polysaccharide chain structure: The molecule uses lactose as the core skeleton, which is sequentially connected to N-acetyl lactose units, fucosyl groups, and is modified with sialic acid (usually N-acetylneuraminic acid) at the non-reducing end. This specific sequence and connection method (α-2,3/α-2,6 sialic acid bond, α-1,2/α-1,3/α-1,4 fucose bond, etc.) is the structural basis of its biological activity.

Dual-functional modification synergy: Carrying negatively charged sialic acid and neutral fucose at the same time enables SLNFP-V to interact with biological targets through multiple molecular recognition mechanisms. The sialic acid part mediates specific binding to sialic acid-binding proteins (such as selectins, Siglecs), while the fucose structure can target fucose-specific lectins, such as DC-SIGN.

Excellent stability and diversity: Its glycosidic bonds are carefully designed to show good stability under appropriate physiological environments. At the same time, as an important member of the HMOs family, subtle differences in its structure (isomers) can correspond to different biological functions, providing the possibility for precise intervention.

Main applications and advantages

1. Core ingredients for the next generation of infant nutrition and health

Simulated breast milk gold standard: SLNFP-V is an important functional oligosaccharide in breast milk. Direct supplementation can help formula foods to be closer to the composition and function of breast milk, support healthy colonization of infant intestinal flora (significantly promote the growth of probiotics such as Bifidobacterium), and inhibit pathogen adhesion.

Double barrier and immune enlightenment: Its sialic acid component is an important nutrient required for brain development and cognitive function. It can also serve as a "bait" receptor to block the binding of pathogens (such as rotavirus, Campylobacter) to the intestinal epithelium. The fucose part is involved in regulating immune responses, helping to train the immune system of infants and young children, and reducing the risk of allergies and inflammation.

2. Trojan Horse for Innovative Drug Design and Targeted Delivery

Targeted drug carrier: Taking advantage of the high affinity recognition of SLNFP-V by specific tissues (such as intestinal tract, immune cells), it can be coupled to drugs, nucleic acids or nanoparticles as a targeting head group to achieve precise delivery of drugs, improve efficacy and reduce systemic toxicity.

Natural template for anti-adhesion therapies: Many pathogens and toxins initiate infection by recognizing sugar chain structures on the cell surface, such as sequences containing sialic acid or fucose. SLNFP-V can be used as a highly efficient competitive inhibitor to block this process and develop new anti-adhesion drugs for preventing or treating gastrointestinal and respiratory infections.

3. Precision tools for immune regulation and inflammation management

Direct dialogue with immune cells: SLNFP-V can bind to specific lectin receptors (such as Siglecs, DC-SIGN) on the surface of immune cells, transmit regulatory signals, and finely regulate the release of inflammatory factors, showing potential in the intervention of autoimmune diseases, allergies, or excessive inflammatory reactions.

Key regulator of the gut-immune axis: By shaping a healthy intestinal microbiome, it indirectly affects systemic immune homeostasis, providing new pathways for nutritional and therapeutic intervention in metabolic diseases and neuroimmune diseases.

4. The cornerstone of cutting-edge research and diagnostic development

Standards and probes for glycobiology research: High-purity SLNFP-V is an indispensable tool molecule for studying sugar-protein interactions and sugar-mediated signaling pathways, helping to decipher the complex sugar codes in life processes.

Disease biomarkers and detection targets: Abnormal expression of specific SLNFP-V structures in serum or tissues may be associated with certain cancers or disease states. It can also be used as a sensitive probe component for detecting pathogens or specific lectins, and can be used to develop new diagnostic reagents.

Conclusion

Sialyl-L-lactose-N-fucopentose V (SLNFP-V) is much more than just one sugar molecule. It is the key executor of the early protection and development program of life endowed by natural evolution, and it is also an intelligent key in the hands of modern scientists that opens the door to precision nutrition, targeted therapy and immune regulation. From optimizing the next generation of formula foods to designing innovative treatments for the intestinal tract and immune system, the multi-dimensional biological functions it exhibits are constantly expanding the boundaries of our imagination for the application of glycoscience.